Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Triarico S, Romano A, Attinà G, Capozza MA, Maurizi P, Mastrangelo S, Ruggiero A.
Int J Mol Sci. 2021 Apr 16;22(8):4112. doi: 10.3390/ijms22084112.
N-[11C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium.
The MICAD Research Team.
2006 Jun 24 [updated 2006 Jul 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Overcoming inhibitions.
Kellar KJ.
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13263-4. doi: 10.1073/pnas.0606052103. Epub 2006 Aug 28.
Treating organophosphates poisoning: management challenges and potential solutions.
Alozi M, Rawas-Qalaji M.
Crit Rev Toxicol. 2020 Oct;50(9):764-779. doi: 10.1080/10408444.2020.1837069. Epub 2020 Nov 13.
Therapy for nerve agent poisoning.
Newmark J.
Arch Neurol. 2004 May;61(5):649-52. doi: 10.1001/archneur.61.5.649.
Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.
Masson P, Nachon F.
J Neurochem. 2017 Aug;142 Suppl 2:26-40. doi: 10.1111/jnc.14026. Epub 2017 May 21.
Pharmacologic prophylaxis against nerve agent poisoning.
Layish I, Krivoy A, Rotman E, Finkelstein A, Tashma Z, Yehezkelli Y.
Isr Med Assoc J. 2005 Mar;7(3):182-7.
Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.
Iyengar AR, Pande AH.
Protein J. 2016 Dec;35(6):424-439. doi: 10.1007/s10930-016-9686-6.
Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable?
Myhrer T, Aas P.
Neurosci Biobehav Rev. 2016 Dec;71:657-670. doi: 10.1016/j.neubiorev.2016.10.017. Epub 2016 Oct 20.
Nerve agents.
Newmark J.
Neurologist. 2007 Jan;13(1):20-32. doi: 10.1097/01.nrl.0000252923.04894.53.
